Ads
related to: drug company- Experts
Our experts are on hand to help you
solve drug development challenges.
- Locations
State-of-the-art drug manufacturing
facilities and expertise. UK & US.
- Contact
Contact our experts about your
drug development programs & needs
- Manifesto
Molecule to cure. Fast. Because
humanity needs solutions. Fast.
- Analytical Services
Candidate screening
Analytical development
- Events
Meet our experts at global events.
Schedule a meeting with us.
- Experts
Search results
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
AOL· 6 days agoMerck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and ...
Snowflake denies cyber-thieves broke through its security
The Register· 3 days agoInfosec analysts at Hudson Rock believe Snowflake was compromised by miscreants who used that...
Warnings Sent For Potential Salmonella Cucumber Contamination - West Virginia Public Broadcasting
West Virginia Public Broadcasting· 12 hours agoThe FDA announced a recall of cucumbers potentially contaminated with salmonella that were sent to...
6 Common Campaign Themes of Democrats Leading Polls
The New York Times via Yahoo News· 2 days agoRecent polls contain a surprising combination of results: Democrats appear to be leading in six tough Senate races even as President Joe Biden trails...
Death row gone rogue: It’s time to regulate lethal injection drugs
The Hill· 7 days agoThe efficacy and safety of execution by lethal injection depends on the efficacy and safety of the...
Exclusive | Merck Nears $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 6 days agoSuch an acquisition would steer a company known for its cancer immunotherapy, Keytruda, into the...
Electric shock for withdrawal? Chesterfield takes a chance on new device for addiction
Richmond Times-Dispatch· 19 hours agoChesterfield’s jail has debuted a new technology for helping addicts. The “Bridge” sends electric...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoThat investment comes after the company agreed to buy Karuna Therapeutics, a neuroscience-drug company, for $14 billion late last year and acquire the...
North American Morning Briefing: Stock Futures Struggle, Yields Spike on Rate Fears
Morningstar· 6 days agoOPENING CALL Stock futures declined on Wednesday and bond yields spiked as Neel Kashkari refused to rule out interest-rate hikes. Investors now are pricing in just a 45.8% probability that the Federal Reserve will cut interest rates by 25 basis
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR...
Morningstar· 6 days agoEfficacy and safety of AFM24 in combination with atezolizumab, a checkpoint inhibitor, is being evaluated in non-small cell lung cancer patients with EGFR wild-type and EGFR mutant advanced/ ...
